CircRNA hsa_circ_0069,399 as a potential clinical prognostic marker in laryngeal squamous cell carcinoma

  • 0The Second Clinical Medical College, Ningxia Medical University, 750000 Yinchuan, Ningxia, China.

|

|

Summary

This summary is machine-generated.

Circular RNAs (circRNAs) play a role in cancer. This study identified hsa_circ_0069,399 as a potential prognostic biomarker for laryngeal squamous cell carcinoma (LSCC) due to its upregulation in tumor tissues.

Area Of Science

  • Oncology
  • Molecular Biology
  • Genetics

Background

  • Circular RNAs (circRNAs) are increasingly recognized for their roles in tumor progression, including invasion, metastasis, and apoptosis.
  • The specific involvement of circRNAs in laryngeal squamous cell carcinoma (LSCC) pathogenesis remains largely uncharacterized.
  • Identifying novel biomarkers is crucial for improving LSCC diagnosis and prognosis.

Purpose Of The Study

  • To investigate circRNA expression profiles in LSCC tissues compared to adjacent non-tumorous tissues.
  • To identify potential circRNA biomarkers for LSCC.
  • To explore the regulatory network of circRNAs in LSCC.

Main Methods

  • Transcriptomic sequencing and bioinformatics analysis were employed to profile circRNAs in LSCC and adjacent tissues from ten patients.
  • A competitive endogenous RNA (ceRNA) network was constructed to elucidate circRNA-miRNA-mRNA interactions.
  • Quantitative real-time PCR (RT-qPCR) and immunohistochemistry were used for validation of key circRNAs and mRNAs.

Main Results

  • A total of 126 differentially expressed circRNAs were identified, with 40 upregulated and 86 downregulated.
  • Ninety-two circRNA-miRNA-mRNA regulatory axes were linked to clinical immunohistochemical indicators, focusing on five candidate circRNAs.
  • The circRNA hsa_circ_0069,399 was found to be significantly upregulated in LSCC tissues and involved in regulatory axes with MKI67 and TP53.

Conclusions

  • The circRNA hsa_circ_0069,399 exhibits differential expression in LSCC.
  • hsa_circ_0069,399 demonstrates potential as a diagnostic or prognostic biomarker for laryngeal squamous cell carcinoma.